This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique cyclopropane structure, combined with the fluorine substituent, makes it a valuable building block for developing drugs with enhanced metabolic stability and bioavailability. It is particularly significant in the creation of central nervous system (CNS) targeting medications, where the fluorine atom can improve the compound's ability to cross the blood-brain barrier. Additionally, its tosylate salt form enhances solubility, facilitating easier handling and formulation during drug development processes. This chemical is also explored in the research of novel therapeutic agents for treating neurological disorders and other conditions requiring precise molecular interactions.